Description of neurotoxicity in a series of patients treated with CAR T-cell therapy

Chimeric antigen receptor-modified T (CAR T) cell therapy is a highly promising treatment for haematological malignancies but is frequently associated with cytokine release syndrome and neurotoxicity. Between July 2018 and July 2019, all patients treated with CD19-targeted CAR T-cell therapy for rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Belin, Catherine, Devic, Perrine, Ayrignac, Xavier, Dos Santos, Amélie, Paix, Adrien, Sirven-Villaros, Lila, Simard, Claire, Lamure, Sylvain, Gastinne, Thomas, Ursu, Renata, Berger, Colette, Platon, Laura, Tessoulin, Benoît, Azoulay, Elie, Wallet, Florent, Thieblemont, Catherine, Bachy, Emmanuel, Cartron, Guillaume, Laplaud, David A., Carpentier, Antoine F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642402/
https://www.ncbi.nlm.nih.gov/pubmed/33149178
http://dx.doi.org/10.1038/s41598-020-76055-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642402/
https://www.ncbi.nlm.nih.gov/pubmed/33149178
http://dx.doi.org/10.1038/s41598-020-76055-9

Ejemplares similares